Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the information disclosed is true, accurate, complete, and free from false records, misleading statements, or significant omissions.
Guangzhou Pharmaceutical Holdings Limited (hereinafter referred to as "Guangzhou Pharmaceutical") has received approval from the China Securities Regulatory Commission for its application to absorb and merge with the Company by exchanging newly issued A-shares and purchasing assets from Guangzhou Medical Group Co., Ltd.
According to the share exchange merger plan, the Company has submitted an application to the Shenzhen Stock Exchange for the termination of its stock listing. The Shenzhen Stock Exchange has agreed to the termination of the Company's ordinary shares listed in RMB, effective from April 26, 2013 (Friday). The relevant information regarding the termination of the Company's stock listing is as follows:
| Stock Nature | Ordinary Shares in RMB |
|---|---|
| Stock Abbreviation | Baiyunshan A |
| Stock Code | 000522 |
| Termination Date | April 26, 2013 |